Equillium, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ANEB
Anebulo Pharmaceuticals, Inc. |
$1.46 | $56.28 M | -5.86 | 2 | $0 |
ANTX
AN2 Therapeutics, Inc. |
$1.26 | $60.55 M | -0.81 | 41 | $0 |
BCAB
BioAtla, Inc. |
$0.53 | $73.14 M | -0.61 | 65 | $0 |
BOLT
Bolt Biotherapeutics, Inc. |
$0.54 | $29.02 M | -0.46 | 100 | $7.88 M |
CHRS
Coherus BioSciences, Inc. |
$1.47 | $193.89 M | -2.28 | 235 | $257.24 M |
CINGW
Cingulate Inc. |
$0.07 | $4.47 M | -0.01 | 13 | $0 |
CUE
Cue Biopharma, Inc. |
$1.51 | $71.99 M | -1.38 | 53 | $5.49 M |
CVKD
Cadrenal Therapeutics, Inc. Common Stock |
$16.26 | $7.53 M | 0 | 4 | $0 |
EWTX
Edgewise Therapeutics, Inc. |
$24.12 | $1.65 B | -11.47 | 108 | $0 |
GRCL
Gracell Biotechnologies Inc. |
$10.25 | $989.87 M | -10.57 | 314 | $0 |
HOOK
HOOKIPA Pharma Inc. |
$2.15 | $79.07 M | -1.71 | 151 | $20.13 M |
HOWL
Werewolf Therapeutics, Inc. |
$1.39 | $151.66 M | -3.17 | 45 | $19.94 M |
IKNA
Ikena Oncology, Inc. |
$1.55 | $84.45 M | -1.11 | 14 | $9.16 M |
JSPR
Jasper Therapeutics, Inc. |
$7.02 | $369.90 M | -0.4 | 45 | $0 |
KTTA
Pasithea Therapeutics Corp. |
$2.64 | $5.84 M | -0.41 | 8 | $0 |
LIAN
LianBio |
$0.32 | $34.47 M | -0.39 | 163 | $0 |
LIFE
aTyr Pharma, Inc. |
$1.90 | $131.12 M | -2.16 | 56 | $353,000 |
LYRA
Lyra Therapeutics, Inc. |
$0.20 | $19.53 M | -0.27 | 88 | $1.56 M |
MNPR
Monopar Therapeutics Inc. |
$25.35 | $14.18 M | -1.56 | 9 | $0 |
NLTX
Neoleukin Therapeutics, Inc. |
$3.49 | $8.20 M | -0.28 | 7 | $0 |
QNRX
Quoin Pharmaceuticals, Ltd. |
$0.60 | $2.73 M | -0.11 | 4 | $0 |
SABS
SAB Biotherapeutics, Inc. |
$3.84 | $27.17 M | -0.44 | 57 | $2.24 M |
SPRO
Spero Therapeutics, Inc. |
$0.98 | $75.85 M | 3.19 | 46 | $96.74 M |
TRVI
Trevi Therapeutics, Inc. |
$3.81 | $171.86 M | -7.18 | 27 | $0 |